Inventor
LANGE III LOUIS G
US16 patents
⚠️ This page may combine multiple inventors who share the name “LANGE III LOUIS G”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
LANGE III LOUIS G
4 patentsUS5063210ANov 5, 1991
Use of sulfated polysaccharides to decrease cholesterol and fatty acid absorption
LANGE III LOUIS G54 citations95
US5017565AMay 21, 1991
Use of sulfated polysaccharides to inhibit pancreatic cholesterol esterase
LANGE III LOUIS G25 citations91
US5352601AOct 4, 1994
Method for recovering purified 52,000 dalton fraction of human pancreatic cholesterol esterase using deae-cellulose, hydroxyapatite and heparin-sepharose
LANGE III LOUIS G9 citations70
US5492822AFeb 20, 1996
Method for recovering purified 100,000 dalton molecular weight fraction of human pancreatic cholesterol esterase
LANGE III LOUIS G4 citations59
(unassigned)
4 patentsUS5616570AApr 1, 1997
Use of non-absorbable synthetic sulfated polysaccharides to decrease cholesterol absorbtion
19 citations92
US5484777AJan 16, 1996
Pancreatic cholesterol esterase inhibitor
22 citations92
US5432058AJul 11, 1995
Method for measuring human cholesterol absorption using metabolically stable isotopes
35 citations85
US6107026AAug 22, 2000
Methods and reagents for RFLP analysis of the human pancreatic cholesterol esterase gene
2 citations50
CV THERAPEUTICS
3 patentsUS5869537AFeb 9, 1999
Macrophage lipid chemoattractant
CV THERAPEUTICS10 citations72
US5429937AJul 4, 1995
Method for recovering purified 100,000 molecular weight fraction of human pancreatic cholesterol esterase using heparin agarose
CV THERAPEUTICS2 citations59
US5663450ASep 2, 1997
Macrophage lipid chemoattractant
CV THERAPEUTICS1 citations51
CV THERAPEUTICS INC
3 patentsUS7071174B1Jul 4, 2006
Method and composition for inhibiting cholesterol esterase
CV THERAPEUTICS INC2 citations62
US5521303AMay 28, 1996
Method of manufacturing non-absorbable synthetic sulfated polysaccharides
CV THERAPEUTICS INC4 citations62
US6632801B1Oct 14, 2003
Method and composition for inhibiting human cholesterol esterase
CV THERAPEUTICS INC1 citations52